Macrogenics (MGNX) Shares Outstanding (Diluted) (2012 - 2026)
Powered by 
Analysis
Macrogenics (MGNX) Shares Outstanding (Diluted) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 66.03 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 115.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 138.28 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 556.90 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Macrogenics | 281.09 Mn | 167.18 Mn | - | 63.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.59 Mn |
| Mar 31, 2026 | 63.45 Mn |
| Dec 31, 2025 | 63.16 Mn |
| Sep 30, 2025 | 63.28 Mn |
| Jun 30, 2025 | 63.14 Mn |
| Mar 31, 2025 | 62.97 Mn |
| Dec 31, 2024 | 62.62 Mn |
| Sep 30, 2024 | 62.87 Mn |
| Jun 30, 2024 | 62.66 Mn |
| Mar 31, 2024 | 62.29 Mn |
| Dec 31, 2023 | 61.93 Mn |
| Sep 30, 2023 | 62.24 Mn |
| Jun 30, 2023 | 62.26 Mn |
| Mar 31, 2023 | 61.81 Mn |
| Dec 31, 2022 | 61.43 Mn |
| Sep 30, 2022 | 61.46 Mn |
| Jun 30, 2022 | 61.38 Mn |
| Mar 31, 2022 | 61.32 Mn |
| Dec 31, 2021 | 59.94 Mn |
| Sep 30, 2021 | 61.17 Mn |